Annual Retained Earnings
-$738.77 M
-$193.57 M-35.50%
November 30, 2024
Summary
- As of February 7, 2025, NRIX annual retained earnings is -$738.77 million, with the most recent change of -$193.57 million (-35.50%) on November 30, 2024.
- During the last 3 years, NRIX annual retained earnings has fallen by -$517.88 million (-234.45%).
- NRIX annual retained earnings is now -1806.16% below its all-time high of -$38.76 million, reached on November 30, 2018.
Performance
NRIX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$738.77 M
-$58.55 M-8.61%
November 30, 2024
Summary
- As of February 7, 2025, NRIX quarterly retained earnings is -$738.77 million, with the most recent change of -$58.55 million (-8.61%) on November 30, 2024.
- Over the past year, NRIX quarterly retained earnings has dropped by -$152.05 million (-25.92%).
- NRIX quarterly retained earnings is now -1121.99% below its all-time high of -$60.46 million, reached on November 30, 2019.
Performance
NRIX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NRIX Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -35.5% | -25.9% |
3 y3 years | -234.4% | -67.2% |
5 y5 years | -1122.0% | -67.2% |
NRIX Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -234.4% | at low | -234.4% | at low |
5 y | 5-year | -1122.0% | at low | -1122.0% | at low |
alltime | all time | -1806.2% | at low | -1122.0% | at low |
Nurix Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Nov 2024 | -$738.77 M(+35.5%) | -$738.77 M(+8.6%) |
Aug 2024 | - | -$680.22 M(+7.8%) |
May 2024 | - | -$631.26 M(+7.6%) |
Feb 2024 | - | -$586.72 M(+7.6%) |
Nov 2023 | -$545.20 M(+35.9%) | -$545.20 M(+8.3%) |
Aug 2023 | - | -$503.24 M(+7.9%) |
May 2023 | - | -$466.26 M(+5.5%) |
Feb 2023 | - | -$441.99 M(+10.2%) |
Nov 2022 | -$401.25 M | -$401.25 M(+13.2%) |
Aug 2022 | - | -$354.54 M(+14.8%) |
Date | Annual | Quarterly |
---|---|---|
May 2022 | - | -$308.83 M(+17.2%) |
Feb 2022 | - | -$263.43 M(+19.3%) |
Nov 2021 | -$220.89 M(+113.0%) | -$220.89 M(+20.6%) |
Aug 2021 | - | -$183.19 M(+18.7%) |
May 2021 | - | -$154.35 M(+20.6%) |
Feb 2021 | - | -$127.97 M(+23.4%) |
Nov 2020 | -$103.70 M(+71.5%) | -$103.70 M(+23.8%) |
Aug 2020 | - | -$83.78 M(+28.4%) |
May 2020 | - | -$65.27 M(+8.0%) |
Nov 2019 | -$60.46 M(+56.0%) | -$60.46 M |
Nov 2018 | -$38.76 M | - |
FAQ
- What is Nurix Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Nurix Therapeutics?
- What is Nurix Therapeutics annual retained earnings year-on-year change?
- What is Nurix Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly retained earnings year-on-year change?
What is Nurix Therapeutics annual retained earnings?
The current annual retained earnings of NRIX is -$738.77 M
What is the all time high annual retained earnings for Nurix Therapeutics?
Nurix Therapeutics all-time high annual retained earnings is -$38.76 M
What is Nurix Therapeutics annual retained earnings year-on-year change?
Over the past year, NRIX annual retained earnings has changed by -$193.57 M (-35.50%)
What is Nurix Therapeutics quarterly retained earnings?
The current quarterly retained earnings of NRIX is -$738.77 M
What is the all time high quarterly retained earnings for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly retained earnings is -$60.46 M
What is Nurix Therapeutics quarterly retained earnings year-on-year change?
Over the past year, NRIX quarterly retained earnings has changed by -$152.05 M (-25.92%)